The beta-blocking drugs in hyperthyroidism. 3. Effects on the post-thyroidectomy course and on the thyrotoxic crisis
Giardina, F.; Bellotti, G.; De Gregori, M.E.; Ghidini, O.
Minerva Medica 62(26): 1383-1392
1971
ISSN/ISBN: 0026-4806 PMID: 5108134 Document Number: 39123
Document emailed within 1 workday
Related Documents
Morosini, P.P.; Fianchini, A.; Landi, E. 1988: Surgical treatment of hyperthyroidism: total thyroidectomy versus subtotal thyroidectomy Il Giornale di Chirurgia 9(3-4): 210-212Duggan, M.A.; Court, J.B. 1981: A proposed mechanism of production of the autoimmune and lymphoproliferative side-effects of beta-adrenergic-site-blocking drugs and hydantoin anticonvulsants Annals of Clinical Research 13(6): 406-418
Bricaire, H.; Pandos 1971: Clinical study on the action of a beta blocking agent (LB 46) on some manifestations of hyperthyroidism and hypothyroidism La Presse Medicale 79(51): 2301-2304
Imai, S. 1975: Action mechanism of anti-hypertensive drugs, with special reference to beta blocking drugs Nihon Jinzo Gakkai Shi 17(7): 674-677
Krum, H.; Pillay, P. 1998: New drugs, old drugs. Beta-adrenoceptor blocking agents Medical Journal of Australia 168(5): 232-235
Ursu, H.I.; Dumitriu, L.; Grigorie, D.; Simescu, M.; Vaida, E.; Belgun, M.; Popovici, D. 1993: Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease) Romanian Journal of Endocrinology 31(3-4): 155-163
Slawin, S. 1973: Beta adrenergic blocking drugs Harefuah 85(4): 178-183
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Walters, L.; Dormehl, I.; Goosen, D.J.; Avenant, J.C.; Du Plessis, M.; Jacobs, N.; Schoeman, H.S. 1983: Beta-adrenergic blocking drugs and renal function South African Medical Journal 64(15): 572-573
Lorimer, A.R.; Jones, J.V.; Clark, B.; Dunn, F.G.; Melville, D.; Lawrie, T.D. 1976: Indications for beta-adrenoceptor blocking drugs in hypertension Postgraduate Medical Journal 52(Suppl 4): 81-85
Sharma, P.L. 1976: Clinical pharmacology of adrenergic beta-receptor blocking drugs Journal of the Association of Physicians of India 24(11): 729-735
Balant, L.; Gorgia, A.; Tschopp, J.M.; Revillard, C.; Fabre, J. 1976: Pharmacokinetics of two beta blocking drugs: detection of a pharmacogenetic abnormality Schweizerische Medizinische Wochenschrift 106(41): 1403-1407
Sillevis Smitt, J.H.; van Joost, T. 1981: Beta-adrenoreceptor blocking drugs and epicutaneous allergologic studies Nederlands Tijdschrift Voor Geneeskunde 125(1): 17-18
Gettes, L.S. 1970: Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias Cardiovascular Clinics 2(2): 211-237
Mills, T.A.; Kawji, M.M.; Cataldo, V.D.; Pappas, N.D.; O'Meallie, L.P.; Breaux, D.M.; Glancy, D.L. 2004: Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 156(6): 327-331
Wayne, V.S.; Harper, R.W.; Laufer, E.; Federman, J.; Anderson, S.T.; Pitt, A. 1982: Adverse interaction between beta-adrenergic blocking drugs and verapamil--report of three cases Australian and New Zealand Journal of Medicine 12(4): 285-289
Mellgren, G.; Holm, P.ål.I.; Lien, E.A.ør.; Bleskestad, I.H.; Aanderud, S.; Bindoff, L. 2002: Thyrotoxic periodic paralysis--an unusual complication of hyperthyroidism Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 122(10): 1029-1031
Salih, M.; van Kinschot, C.M.J.; Peeters, R.P.; de Herder, W.W.; Duschek, E.J.J.; van der Linden, J.; van Noord, C. 2017: Thyrotoxic periodic paralysis: an unusual presentation of hyperthyroidism Netherlands Journal of Medicine 75(8): 315-320
Alvan, G.; von Bahr, C.; Seidemann, P.; Sjöqvist, F. 1982: High plasma concentrations of beta-receptor blocking drugs and deficient debrisoquine hydroxylation Lancet 1(8267): 333
Merin, R.G. 1972: Anesthetic management problems posed by therapeutic advances: 3. Beta-adrenergic blocking drugs Anesthesia and Analgesia 51(4): 617-624